Meeder Asset Management Inc Medicinova Inc Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 17, 2019	SELL	$7.7 - $10.42 $254 - $343	-33 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$8.29 - $13.22 $4,576 - $7,297	-552 Reduced 94.36%	33 $0
Q1 2019 Apr 16, 2019	BUY	$6.82 - $10.27 $381 - $575	56 Added 10.59%	585 $5,000
Q4 2018 Jan 17, 2019	BUY	$7.65 - $12.83 $4,046 - $6,787	529 New	529 $4,000
Q3 2018 Nov 02, 2018	SELL	$7.06 - $12.49 $840 - $1,486	-119 Closed	0 $0
Q2 2018 Jul 24, 2018	SELL	$7.96 - $13.23 $7,211 - $11,986	-906 Reduced 88.39%	119 $0
Q1 2018 May 03, 2018	BUY	$6.6 - $13.91 $646 - $1,363	98 Added 10.57%	1,025 $11,000
Q4 2017 Feb 02, 2018	BUY	$5.89 - $7.21 $424 - $519	72 Added 8.42%	927 $5,000
Q3 2017 Oct 20, 2017	BUY	$4.43 - $6.58 $3,787 - $5,625	855	855 $5,000

5.13M

Ticker MNOV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,046,200
Market Cap $96.1M
Description
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.